Global Equine Influenza Vaccine Market Growth 2022-2028
- LP 4794682
- 75 Pages
- January 2022
- Pharmaceuticals
The United States Equine Influenza Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Equine Influenza Vaccine market, reaching US$ million by the year 2028. As for the Europe Equine Influenza Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Equine Influenza Vaccine players cover Zoetis, Merck Animal Health, Boehringer Ingelheim Vetmedica, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Liquid
Powder
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Home
Pet Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Equine Influenza Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Equine Influenza Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Equine Influenza Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Equine Influenza Vaccine Segment by Type
2.2.1 Liquid
2.2.2 Powder
2.3 Equine Influenza Vaccine Sales by Type
2.3.1 Global Equine Influenza Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Equine Influenza Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Equine Influenza Vaccine Sale Price by Type (2017-2022)
2.4 Equine Influenza Vaccine Segment by Application
2.4.1 Home
2.4.2 Pet Clinic
2.4.3 Others
2.5 Equine Influenza Vaccine Sales by Application
2.5.1 Global Equine Influenza Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Equine Influenza Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Equine Influenza Vaccine Sale Price by Application (2017-2022)
3 Global Equine Influenza Vaccine by Company
3.1 Global Equine Influenza Vaccine Breakdown Data by Company
3.1.1 Global Equine Influenza Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Equine Influenza Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Equine Influenza Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Equine Influenza Vaccine Revenue by Company (2020-2022)
3.2.2 Global Equine Influenza Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Equine Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Equine Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Influenza Vaccine Product Location Distribution
3.4.2 Players Equine Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Equine Influenza Vaccine by Geographic Region
4.1 World Historic Equine Influenza Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Equine Influenza Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Equine Influenza Vaccine Annual Revenue by Geographic Region
4.2 World Historic Equine Influenza Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Equine Influenza Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Equine Influenza Vaccine Annual Revenue by Country/Region
4.3 Americas Equine Influenza Vaccine Sales Growth
4.4 APAC Equine Influenza Vaccine Sales Growth
4.5 Europe Equine Influenza Vaccine Sales Growth
4.6 Middle East & Africa Equine Influenza Vaccine Sales Growth
5 Americas
5.1 Americas Equine Influenza Vaccine Sales by Country
5.1.1 Americas Equine Influenza Vaccine Sales by Country (2017-2022)
5.1.2 Americas Equine Influenza Vaccine Revenue by Country (2017-2022)
5.2 Americas Equine Influenza Vaccine Sales by Type
5.3 Americas Equine Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Influenza Vaccine Sales by Region
6.1.1 APAC Equine Influenza Vaccine Sales by Region (2017-2022)
6.1.2 APAC Equine Influenza Vaccine Revenue by Region (2017-2022)
6.2 APAC Equine Influenza Vaccine Sales by Type
6.3 APAC Equine Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Equine Influenza Vaccine by Country
7.1.1 Europe Equine Influenza Vaccine Sales by Country (2017-2022)
7.1.2 Europe Equine Influenza Vaccine Revenue by Country (2017-2022)
7.2 Europe Equine Influenza Vaccine Sales by Type
7.3 Europe Equine Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Equine Influenza Vaccine by Country
8.1.1 Middle East & Africa Equine Influenza Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Equine Influenza Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Equine Influenza Vaccine Sales by Type
8.3 Middle East & Africa Equine Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Influenza Vaccine
10.3 Manufacturing Process Analysis of Equine Influenza Vaccine
10.4 Industry Chain Structure of Equine Influenza Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Influenza Vaccine Distributors
11.3 Equine Influenza Vaccine Customer
12 World Forecast Review for Equine Influenza Vaccine by Geographic Region
12.1 Global Equine Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Equine Influenza Vaccine Forecast by Region (2023-2028)
12.1.2 Global Equine Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Equine Influenza Vaccine Forecast by Type
12.7 Global Equine Influenza Vaccine Forecast by Application
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Equine Influenza Vaccine Product Offered
13.1.3 Zoetis Equine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Equine Influenza Vaccine Product Offered
13.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Boehringer Ingelheim Vetmedica
13.3.1 Boehringer Ingelheim Vetmedica Company Information
13.3.2 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Offered
13.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Vetmedica Main Business Overview
13.3.5 Boehringer Ingelheim Vetmedica Latest Developments
14 Research Findings and Conclusion
Table 1. Equine Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Equine Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 6. Global Equine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Equine Influenza Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Equine Influenza Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Equine Influenza Vaccine Sale Price by Type (2017-2022) & (USD/Dose)
Table 10. Global Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 11. Global Equine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Equine Influenza Vaccine Revenue by Application (2017-2022)
Table 13. Global Equine Influenza Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Equine Influenza Vaccine Sale Price by Application (2017-2022) & (USD/Dose)
Table 15. Global Equine Influenza Vaccine Sales by Company (2020-2022) & (K Doses)
Table 16. Global Equine Influenza Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Equine Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Equine Influenza Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Equine Influenza Vaccine Sale Price by Company (2020-2022) & (USD/Dose)
Table 20. Key Manufacturers Equine Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Equine Influenza Vaccine Products Offered
Table 22. Equine Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Equine Influenza Vaccine Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Equine Influenza Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Equine Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Equine Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Equine Influenza Vaccine Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Equine Influenza Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Equine Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Equine Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Equine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Equine Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Equine Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Equine Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Equine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Equine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Equine Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Equine Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Equine Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Equine Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Equine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Equine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Equine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Equine Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Equine Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Equine Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Equine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Equine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Equine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Equine Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Equine Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Equine Influenza Vaccine
Table 66. Key Market Challenges & Risks of Equine Influenza Vaccine
Table 67. Key Industry Trends of Equine Influenza Vaccine
Table 68. Equine Influenza Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Equine Influenza Vaccine Distributors List
Table 71. Equine Influenza Vaccine Customer List
Table 72. Global Equine Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Equine Influenza Vaccine Sales Market Forecast by Region
Table 74. Global Equine Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Equine Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Equine Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Equine Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Equine Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Equine Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Equine Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Equine Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Equine Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Equine Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Equine Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Equine Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Equine Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Equine Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Equine Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Equine Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Equine Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Equine Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Zoetis Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Zoetis Equine Influenza Vaccine Product Offered
Table 94. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 95. Zoetis Main Business
Table 96. Zoetis Latest Developments
Table 97. Merck Animal Health Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Animal Health Equine Influenza Vaccine Product Offered
Table 99. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Merck Animal Health Main Business
Table 101. Merck Animal Health Latest Developments
Table 102. Boehringer Ingelheim Vetmedica Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Offered
Table 104. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. Boehringer Ingelheim Vetmedica Main Business
Table 106. Boehringer Ingelheim Vetmedica Latest Developments
List of Figures
Figure 1. Picture of Equine Influenza Vaccine
Figure 2. Equine Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Influenza Vaccine Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Equine Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Equine Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Liquid
Figure 10. Product Picture of Powder
Figure 11. Global Equine Influenza Vaccine Sales Market Share by Type in 2021
Figure 12. Global Equine Influenza Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Equine Influenza Vaccine Consumed in Home
Figure 14. Global Equine Influenza Vaccine Market: Home (2017-2022) & (K Doses)
Figure 15. Equine Influenza Vaccine Consumed in Pet Clinic
Figure 16. Global Equine Influenza Vaccine Market: Pet Clinic (2017-2022) & (K Doses)
Figure 17. Equine Influenza Vaccine Consumed in Others
Figure 18. Global Equine Influenza Vaccine Market: Others (2017-2022) & (K Doses)
Figure 19. Global Equine Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Equine Influenza Vaccine Revenue Market Share by Application in 2021
Figure 21. Equine Influenza Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Equine Influenza Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Equine Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Equine Influenza Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Equine Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Equine Influenza Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Equine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 28. Americas Equine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Equine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 30. APAC Equine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Equine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 32. Europe Equine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Equine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 34. Middle East & Africa Equine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Equine Influenza Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Equine Influenza Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Equine Influenza Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Equine Influenza Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Equine Influenza Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Equine Influenza Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Equine Influenza Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Equine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Equine Influenza Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Equine Influenza Vaccine
Figure 65. Industry Chain Structure of Equine Influenza Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
